- AU$9.91bn
- AU$15.25bn
- AU$10.87bn
Jefferies reduces PT, earnings estimate for Australia's Sonic Healthcare
Brief: Sonic Healthcare Says It Expects FY26 EPS Growth Of Up To About 19%
Australia's Sonic Healthcare slides as FY results miss estimates
Brief: Sonic Healthcare Settles The Acquisition Of Ladr Laboratory Group
Bell Potter initiates coverage on Australia's Sonic Healthcare with a 'buy' rating
Australian healthcare sector growth to be driven by bulk billing and incentives, says Jefferies
Brief: Artrya Secures Multi-Year Contract With Sonic Healthcare
Brief: Sonic Healthcare Receives German Antitrust Clearance To Acquire LADR
Tech startup lawyers swap law firms with Morrison Foerster hires
Citi upbeat on Australia's Sonic Healthcare buying German pathology group; raises PT
Brief: Sonic Healthcare Announces Acquisition Of LADR Laboratory Group In Germany
Australia's Sonic Healthcare rises; Morningstar says shares undervalued
Brief: Sonic Healthcare Says Declares Final Dividend Of 63 Au Cents Per Share
Australia's Sonic Healthcare reverses early losses on FY25 forecast
Brief: Sonic Healthcare Posts FY Net Income AUD 511.1 Mln
Brief: Sonic Healthcare To Raise EUR400 Mln Of Long Term Debt Funding
Macquarie forecasts FY25 EBITDA below consensus for Australia's Sonic Healthcare
Aussie healthcare stocks set to log modest gains in first-half 2024
Australia's Sonic Healthcare extends losses on profit forecast downgrade